DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Kobayashi S, Boggon TJ, Dayaram T. et al.
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.
N Engl J Med 2005;
352 (08) 786-792
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.